Ten cases of feline mesothelioma: an immunohistochemical and ultrastructural study.

[1]  Leushin Nv.  Phenesal and hexachlorophene in canine cestodiasis , 1971 .

[2]  E. Andrews.  Pleural mesothelioma in a cat. , 1973, Journal of comparative pathology.

[3]  C. P. Raflo,et al.  Abdominal Mesothelioma in a Cat , 1978, Veterinary pathology.

[4]  W. Hickey,et al.  Malignant mesothelioma: Ultrastructural distinction from adenocarcinoma , 1982, American Journal of Surgical Pathology.

[5]  潔 秋山,et al.  Psammoma bodies をともなう猫腹膜中皮腫の1例 , 1982 .

[6]  J. Godleski,et al.  Malignant Mesothelioma in Urban Dogs , 1983, Veterinary pathology.

[7]  R R Dubielzig,et al.  Mesothelioma in pet dogs associated with exposure of their owners to asbestos. , 1983, Environmental research.

[8]  R. Julian.  The Peritoneum, Retroperitoneum, and Mesentery , 1985, Pathology of Domestic Animals.

[9]  J. Churg,et al.  Tumors and pseudotumors of the serous membranes , 1985 .

[10]  K. Ochiai,et al.  Malignant mesothelioma with metastases and mast cell leukaemia in a cat. , 1994, Journal of comparative pathology.

[11]  J. Hurlimann.  Desmin and neural marker expression in mesothelial cells and mesotheliomas. , 1994, Human pathology.

[12]  G. Viale,et al.  Calretinin: a novel immunocytochemical marker for mesothelioma. , 1996, The American journal of surgical pathology.

[13]  P. Wohlsein,et al.  Malignant biphasic peritoneal mesothelioma in a horse. , 1997 .

[14]  R. Attanoos,et al.  Anti‐mesothelial markers in sarcomatoid mesothelioma and other spindle cell neoplasms , 2000, Histopathology.

[15]  A. Nicholson,et al.  Value of the Mesothelium-Associated Antibodies Thrombomodulin, Cytokeratin 5/6, Calretinin, and CD44H in Distinguishing Epithelioid Pleural Mesothelioma from Adenocarcinoma Metastatic to the Pleura , 2000, Modern Pathology.

[16]  R. Attanoos,et al.  Malignant epithelioid mesothelioma: anti‐mesothelial marker expression correlates with histological pattern , 2001, Histopathology.

[17]  J. Dahlstrom,et al.  DISTINCTIVE MICROVILLOUS BRUSH BORDER STAINING WITH HBME‐1 DISTINGUISHES PLEURAL MESOTHELIOMAS FROM PULMONARY ADENOCARCINOMAS , 2001, Pathology.

[18]  N. Ordóñez.  Immunohistochemical diagnosis of epithelioid mesotheliomas: a critical review of old markers, new markers. , 2002, Human pathology.

[19]  R. Attanoos,et al.  Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum , 2002, Histopathology.

[20]  B. Addis,et al.  Immunohistochemistry in the distinction between malignant mesothelioma and pulmonary adenocarcinoma: a critical evaluation of new antibodies , 2002, Journal of clinical pathology.

[21]  R. Attanoos,et al.  The use of immunohistochemistry in distinguishing reactive from neoplastic mesothelium. A novel use for desmin and comparative evaluation with epithelial membrane antigen, p53, platelet‐derived growth factor‐receptor, P‐glycoprotein and Bcl‐2 , 2003, Histopathology.

[22]  M Rinke,et al.  Pleural mesothelioma in a young cat. , 2003, DTW. Deutsche tierarztliche Wochenschrift.

[23]  N. Granger,et al.  Mésothéliome pleural chez un chat , 2003 .

[24]  G. Sauter,et al.  Calretinin expression in human normal and neoplastic tissues: a tissue microarray analysis on 5233 tissue samples. , 2003, Human pathology.

[25]  N. Ordóñez.  Value of E-cadherin and N-cadherin immunostaining in the diagnosis of mesothelioma. , 2003, Human pathology.

[26]  P. Betta,et al.  Aberrant E-cadherin and gamma-catenin expression in malignant mesothelioma and its diagnostic and biological relevance. , 2004, Lung cancer.

[27]  S. Mutsaers.  Mesothelial Cell , 2020, Definitions.